Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03807479
Title Study in Patients With Chronic Leukemia, Where Previous Therapy Failed, and Who Will be Treated With Ponatinib as Second Line Therapy (PONS)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GWT-TUD GmbH
Indications

chronic myeloid leukemia

Therapies

Ponatinib

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.